Largest Gift in UCSD History to Fund Stem Cell Research on Space Station – Times of San Diego
stemadminStem Cell ResearchNo comments

Scanning electron micrograph of cultured human neuron from induced pluripotent stem cell. Photo via Mark Ellisman and Thomas Deerinck, National Center for Microscopy and Imaging Research, UC San Diego UC San Diego will use the largest single gift in its history to fund an institute tasked with expanding stem cell research and regenerative medicine, it was announced Tuesday. The $150 million gift from businessman and philanthropist T. Denny Sanford follows up on his $100 million gift in 2013, which established UCSD as a leader in developing and delivering the therapeutic promise of human stem cells

Read more
University of Colorado’s ocular stem cell and regenerative research program recognized – Ophthalmology Times
stemadminStem Cell ResearchNo comments

The University of Colorado Department of Ophthalmologys ocular stem cell and regeneration research program, CellSight, was awarded two prizes in the National Eye Institutes 3D Retinal Organoid Challenge (NEI 3D ROC). The NEI, part of the National Institutes of Health, launched the three-phase challenge in 2017 to stimulate research using retina organoids. These organoids are similar to human retinas but aregrown in a lab from stem cells, enabling researchers to study eye diseases and treatments noninvasively. CellSightDirectorValeria Canto-Soler, PhD, Doni Solich Family Chair in Ocular Stem Cell Research, led the team that won the NEI 3D ROCs disease modeling category, earning $500,000.Natalia Vergara, PhD, director ofCellSightsOcular Development and Translational Technologies Laboratory, led the research group that won the drug-screening category, earning $250,000. According to a University of Colorado news release, Canto-Solers research group created a three-dimensional retinal model that recreates pathological features of age-related macular degeneration, with the ultimate goal of discovering new treatments for this blinding disease

Read more
Global Recombinant Cell Culture Supplements Market Report 2022: Increasing Need for Immunotherapies and Stem Cell and Regenerative Medicines Presents…
stemadminStem Cell ResearchNo comments

Company Logo Global Recombinant Cell Culture Supplements Market Global Recombinant Cell Culture Supplements Market Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Recombinant Cell Culture Supplements Market: Focus on Pricing Analysis, Product, Application, Expression System, and Region - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering. The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032. The growth in the global recombinant cell culture supplements market is expected to be driven by the rising demand for cell culture supplements, increasing investment in life sciences research and development, as well as growing advantages of recombinant supplements over traditional animal-derived supplements. Market Lifecycle Stage The global recombinant cell culture market is increasing at a rapid pace

Read more
ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell Islets for the Treatment of Type 1 Diabetes – Business Wire
stemadminStem Cell ResearchNo comments

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and other metabolic diseases, announces the establishment of a first proof of concept for its AdoShell Islets implant by achieving glycemic control without insulin injections in immunocompetent diabetic rats during the 132-day study. "Adocias results are remarkable, having successfully performed the first islet transplantation without the use of immunosuppressants in immunocompetent animals. We are delighted to be actively involved in these unprecedent results, said Dr. Karim Bouzakri, Director of CEED (European Center for the Study of Diabetes). AdoShell Islets is an immuno-protective synthetic biomaterial containing islets of Langerhans.

Read more
Hill International to Provide Project Management and Supervision Consultancy Services for the International Stem Cell and Regenerative Medicine…
stemadminStem Cell ResearchNo comments

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. PHILADELPHIA and CAIRO, Egypt, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Hill International(NYSE: HIL), delivering the infrastructure of change, announced today it was selected by Egypts Ministry of Defense to provide project management and supervision consultancy services for the International Stem Cell and Regenerative Medicine Research and Therapeutic Center project. The project represents the latest effort of the Egyptian Armed forces to enrich the countrys healthcare sector

Read more
Montreal resident donates to stem cell research hoping it will help her heart Pipa News – PiPa News
stemadminStem Cell ResearchNo comments

Doctors say MUHC has embarked on stem cell research with serious potential to treat a range of diseases, and some of that work was made possible by someone who hoped it would help her. Sharon Steinberg proudly says that she works out three times a week. She is in her 80s and has been exercising as prescribed by her doctor after experiencing troublesome symptoms.

Read more
Utilization of Modified Induced Pluripotent Stem Cells as the Advance | OPTH – Dove Medical Press
stemadminStem Cell ResearchNo comments

Introduction Glaucoma is one of the optic neuropathy disorders characterized by the progressive degeneration of retinal ganglion cells (RGC), which eventually lead to cupping of the optic disc and decreased visual field.1 Glaucoma is also closely related to an increase in intraocular pressure caused by the damage of trabecular meshwork (TBM), which results in optic nerve damage, characterized by the loss of retinal ganglion cells.2,3 Globally, in 2020, more than 76 million people are suffering from glaucoma, and it is expected to increase to 111.8 million people by 2040.4,5 Glaucoma is also a severe and complex medical problem because it often causes blindness. According to the World Health Organization (WHO), the most common causes of blindness are cataracts (51%), followed by glaucoma (8%), and age-related macular degeneration (5%).6 This data shows that glaucoma is the worlds second most common cause of blindness after cataracts. Symptoms that are often asymptomatic at an early stage and the low public awareness have contributed to the disorders seriousness. Handling and treating glaucoma cases is difficult, especially because no therapy can cure glaucoma. Current treatment, both medical and surgical, is focused solely on lowering intraocular pressure

Read more

Theme: Illdy.